North Carolina moves forward with legislative efforts to regulate pharmacy benefit managers, aiming to increase transparency and fair reimbursement for independent pharmacies amid rising drug prices.

New analysis projects increased Medicare spending with expanded GLP-1 receptor agonist coverage for obesity, highlighting clinical benefits and financial challenges.

April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.